NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success - NeuroBo Pharmaceuticals (NASDAQ:NRBO)

NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide.

Related Keywords

Boston ,Massachusetts ,United States ,Novo Nordisk ,Neurobo Pharmaceuticals Inc ,Protein Coupled Receptor ,Price Action ,